Analyst Ratings for Chelsea Therapeutics (CHTP)
CHTP Rating Summary
CHTP Price Target Summary
- Highest: $4.00 (Needham & Company)
- Lowest: $2.25 (Roth Capital)
- Average: $3.13
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$3.13 (+66.2%)
Avg. $ Target:
$3.13 (+66.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/20/2013 | Needham & Company | Upgrade | Buy (Hold) |
4.00 (N/A) |
1.55 | 1.88 | 21.29% | Details |
| 2/20/2013 | Ladenburg Thalmann | Upgrade | Buy (Neutral) |
N/A (N/A) |
1.50 | 1.88 | 25.33% | Details |
| 3/29/2012 | Langenberg & Company | Downgrade | Hold (N/A) |
N/A (N/A) |
2.64 | 1.88 | -28.79% | Details |
| 3/29/2012 | Deutsche Bank » Updated 7/3/2012 |
Downgrade | Hold (N/A) |
N/A (N/A) |
2.64 | 1.88 | -28.79% | Details |
